GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | +3.4% | 11,809 | -2.1% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -42.0% | 12,064 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $50,000 | -67.7% | 12,064 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $155,000 | +19.2% | 12,064 | 0.0% | 0.01% | +11.1% |
| Q3 2021 | $130,000 | +18.2% | 12,064 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $110,000 | -12.7% | 12,064 | -9.4% | 0.01% | -20.0% |
| Q1 2021 | $126,000 | +12.5% | 13,314 | -53.1% | 0.01% | +11.1% |
| Q4 2020 | $112,000 | +28.7% | 28,380 | -13.3% | 0.01% | +12.5% |
| Q3 2020 | $87,000 | -64.0% | 32,740 | -10.0% | 0.01% | -68.0% |
| Q2 2020 | $242,000 | +160.2% | 36,390 | +127.0% | 0.02% | +127.3% |
| Q1 2020 | $93,000 | -35.4% | 16,030 | 0.0% | 0.01% | -26.7% |
| Q4 2019 | $144,000 | – | 16,030 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |